Pfizer (PFE)
$27.94
0.11 (0.39%)
PFE Stock Quote Delayed 30 Minutes
62 Stock Upgrades (and Downgrades) for the Week
During these time it pays to stay on top of the latest profit opportunities. Today's blog post is be a great place to start with these 62 trades to make
Top 5 Stocks for 2024
INSIDE: Investing legend Louis Navellier reveals his Top 5 Stocks for 2024 — FREE!
Download His Free Report Here:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
-
Market Cap
156.65B
PE Ratio
-558.79
EPS
-0.05
Volume (Avg. Vol.)
3.81M
Day's Range
$27.87 - $28.12
52-Week Range
$25.20 - $37.80
Dividend & Yield
$1.64 (5.87%)
PFE Stock Predictions, Articles, and Pfizer News
64 Actions to Take on Monday’s Market Dip
It pays to stay on top of the latest profit opportunities, and today's blog post is a great place to start after Monday's route
Pfizer Inc (PFE) Stock Looks GREAT (Once You Get Past the Noise!)
Pfizer (PFE) stock has been driven lower by chatter and assumption, but strong sales and earnings growth will win out in the end.
4 Healthcare Stocks on Shaky Ground – MRK LLY AZN BMY
Biotechnology stocks have broken down, and certain pharmaceutical stocks are now following suit. Could Merck and other pharmas suffer more downside?
Respect the Pipeline! Pfizer Is a Bargain (PFE)
Pfizer stock has sagged lately, but the deal with Allergan should provide a nice boost in the coming years because of its range of drugs.
Prepare For the Rush With These 41 Dividend Stocks
In this low interest rate environment, dividends are still looking great. Here is a list of 44 dividend stocks set for payouts this quarter
U.S. Corporate Tax Code Hinders Economy
Corporate tax inversions are a boon for companies, but tax cuts are even better.
60 Recommendations for the Earnings Shakeout
these times it pays to stay on top of the latest profit opportunities. Today's post is be the place to start with these 70 stock moves
Why Pfizer is a Top 25 Dividend Giant (PFE)
Pfizer has been named as a Top 25 Dividend Giant by ETF Channel based on these key metrics
Amgen, Boeing, Pfizer Lead 12 Dividend Stocks Increasing Payouts
Among the leading companies moving to make shareholders happy last week was a mega-cap biotechnology giant, a mammoth defense and aerospace contractor, the biggest drug retailer in the world and a Big Pharma behemoth.
63 Trades to Kick Off the Week
During these busy times, it pays to stay on top of the latest profit opportunities. Today's blog post is a great place to start.
The Long Trail Back For the Energy Sector
Kinder Morgan's recent move to cut its dividend signals a start to a long road back for the energy sector
Wall Street Slides Lower in Pre-Holiday Trading
Stocks moved lower on Wall Street today, with consumer staples leading the way and telecom bringing up the rear. Crude saw some overnight volatility, while Pfizer made headlines with an inversion deal with Allergan.
Market Underestimates Pfizer Stock After Allergan Deal
Pfizer stock has been falling on rumors, and then official reports, of a buyout of Allergan, but there's no real downside to this pairing.
Monday’s Vital Data: Apple Inc. (AAPL), Pfizer, Inc. (PFE) and National Bank of Greece (NBG)
Apple (AAPL) calls up on China data. Pfizer (PFE) speculation ahead of Allergan (AGN) deal. National Bank of Greece (NBG) pummeled by puts.
Pfizer Stock Down, But Hardly Out, On Threats to Tax Inversion Law
Pfizer stock took a hit on concerns that it's union with Allergan could be upended by new tax rules in the meantime, but the odds still favor PFE.
Thursday’s Vital Data: Apple Inc. (AAPL), Qualcomm, Inc. (QCOM) and Pfizer Inc. (PFE)
Apple (AAPL) supplier Foxconn's revenue points to strong iPhone sales, while Qualcomm (QCOM) faces antitrust in Korea and Pfizer (PFE) nears a deal with Allergan (AGN).
